Global Antibodies Market - Industry Analysis Size Share Growth Trends and Forecast 2022 - 2030

Global Antibodies Market - Industry Analysis Size Share Growth Trends and Forecast 2022 - 2030

  • SKU :
    SAC2059597
  • Published Date :
    June 1, 2022
  • Number of Pages :
    350.0

Product Description

The Antibodies market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario,  the market for Antibodies is projected to grow from US$ xx million in 2021, and is projected to reach xx by 2030, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.

The report offers detailed coverage of Antibodies industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Antibodies by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Antibodies market are discussed.

The market is segmented by types: 
    Infliximab
    Rituximab
    Trastuzumab
    Adalimumab
    Other

It can be also divided by applications:
    Oncology
    Autoimmune Disease
    Other

And this report covers the historical situation, present status and the future prospects of the global Antibodies market for 2021-2030. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.

Finally, the report provides detailed profile and data information analysis of leading company.
    Celltrion
    Pfizer (Hospira)
    3SBIO
    Novartis (Sandoz)
    Dr ReddyÕs
    Celgen Biopharma
    Cadila Healthcare
    Hisun Pharma
    Torrent Pharmaceuticals

Report Includes:
- xx data tables and xx additional tables
- An overview of global Antibodies market
- An detailed key players analysis across regions
- Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2030
- Insights into regulatory and environmental developments
- Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Antibodies market
- Profiles of major players in the industry, including     Celltrion,     Pfizer (Hospira),     3SBIO,     Novartis (Sandoz),     Dr ReddyÕs.....

Research objectives
    To study and analyze the global Antibodies consumption (value & volume) by key regions/countries, product type and application, history data from 2018 to 2021, and Forecast to 2030.
    To understand the structure of Antibodies market by identifying its various subsegments.
    Focuses on the key global Antibodies manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
    To analyze the Antibodies with respect to individual growth trends, future prospects, and their contribution to the total market.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    To project the consumption of Antibodies submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Content 

Table of Contents

Global Antibodies Market Report 2022, Forecast to 2030

1 Scope of the Study
    1.1 Antibodies Introduction
    1.2 Research Programs
    1.3 Analysis of Macroeconomic Indicators
    1.4 Years Considered
    1.5 Methodology
    1.6 Data Source
    1.7 Research Objectives

2 Antibodies Industry Overview
    2.1 Global Antibodies Market Size (Million USD) Comparison by Regions (2022-2030)
        2.1.1 Antibodies Global Import Market Analysis
        2.1.2 Antibodies Global Export Market Analysis
        2.1.3 Antibodies Global Main Region Market Analysis
    2.2 Market Analysis by Type
        2.2.1 Infliximab
        2.2.2 Rituximab
        2.2.3 Trastuzumab
        2.2.4 Adalimumab
        2.2.5 Other
    2.3 Market Analysis by Application
        2.3.1 Oncology
        2.3.2 Autoimmune Disease
        2.3.3 Other
    2.4 Global Antibodies Revenue, Sales and Market Share by Manufacturer
        2.4.1 Global Antibodies Sales and Market Share by Manufacturer (2018-2021)
        2.4.2 Global Antibodies Revenue and Market Share by Manufacturer (2018-2021)
        2.4.3 Global Antibodies Industry Concentration Ratio (CR5 and HHI)
        2.4.4 Top 5 Antibodies Manufacturer Market Share
        2.4.5 Top 10 Antibodies Manufacturer Market Share
        2.4.6 Date of Key Manufacturers Enter into Antibodies Market
        2.4.7 Key Manufacturers Antibodies Product Offered
        2.4.8 Mergers & Acquisitions Planning
    2.5 Antibodies Historical Development Overview
    2.6 Market Dynamics
        2.6.1 Market Opportunities
        2.6.2 Market Risk
        2.6.3 Market Driving Force
        2.6.4 Porter's Five Forces Analysis
    2.7 Coronavirus Disease 2019 (Covid-19): Antibodies Industry Impact
        2.7.1 How the Covid-19 is Affecting the Antibodies Industry
        2.7.2 Antibodies Business Impact Assessment - Covid-19
        2.7.3 Market Trends and Antibodies Potential Opportunities in the COVID-19 Landscape
        2.7.4 Measures / Proposal against Covid-19

3 Upstream and Downstream Market Analysis
    3.1 Upstream Analysis
        3.1.1 Macro Analysis of Upstream Markets
        3.1.2 Key Players in Upstream Markets
        3.1.3 Upstream Market Trend Analysis
        3.1.4 Antibodies Manufacturing Cost Analysis
    3.2 Downstream Market Analysis
        3.2.1 Macro Analysis of Down Markets
        3.2.2 Key Players in Down Markets
        3.2.3 Downstream Market Trend Analysis
        3.2.4 Sales Channel, Distributors, Traders and Dealers

4 Global Antibodies Market Size Categorized by Regions
    4.1 Global Antibodies Revenue, Sales and Market Share by Regions
        4.1.1 Global Antibodies Sales and Market Share by Regions (2018-2021)
        4.1.2 Global Antibodies Revenue and Market Share by Regions (2018-2021)
    4.2 Europe Antibodies Sales and Growth Rate (2018-2021)
    4.3 APAC Antibodies Sales and Growth Rate (2018-2021)
    4.4 North America Antibodies Sales and Growth Rate (2018-2021)
    4.5 South America Antibodies Sales and Growth Rate (2018-2021)
    4.6 Middle East & Africa Antibodies Sales and Growth Rate (2018-2021)

5 Europe Antibodies Market Size Categorized by Countries
    5.1 Europe Antibodies Sales, Revenue and Market Share by Countries
        5.1.1 Europe Antibodies Sales by Countries (2018-2021)
        5.1.2 Europe Antibodies Revenue by Countries (2018-2021)
        5.1.3 Germany Antibodies Sales and Growth Rate (2018-2021)
        5.1.4 UK Antibodies Sales and Growth Rate (2018-2021)
        5.1.5 France Antibodies Sales and Growth Rate (2018-2021)
        5.1.6 Russia Antibodies Sales and Growth Rate (2018-2021)
        5.1.7 Italy Antibodies Sales and Growth Rate (2018-2021)
        5.1.8 Spain Antibodies Sales and Growth Rate (2018-2021)
    5.2 Europe Antibodies Revenue (Value) by Manufacturers (2018-2021)
    5.3 Europe Antibodies Sales, Revenue and Market Share by Type (2018-2021)
        5.3.1 Europe Antibodies Sales Market Share by Type (2018-2021)
        5.3.2 Europe Antibodies Revenue and Revenue Share by Type (2018-2021)
    5.4 Europe Antibodies Sales Market Share by Application (2018-2021)

6 Asia-Pacific Antibodies Market Size Categorized by Countries
    6.1 Asia-Pacific Antibodies Sales, Revenue and Market Share by Countries
        6.1.1 Asia-Pacific Antibodies Sales by Countries (2018-2021)
        6.1.2 Asia-Pacific Antibodies Revenue by Countries (2018-2021)
        6.1.3 China Antibodies Sales and Growth Rate (2018-2021)
        6.1.4 Japan Antibodies Sales and Growth Rate (2018-2021)
        6.1.5 Korea Antibodies Sales and Growth Rate (2018-2021)
        6.1.6 India Antibodies Sales and Growth Rate (2018-2021)
        6.1.7 Southeast Asia Antibodies Sales and Growth Rate (2018-2021)
        6.1.8 Australia Antibodies Sales and Growth Rate (2018-2021)
    6.2 Asia-Pacific Antibodies Sales and Revenue (Value) by Manufacturers (2018-2021)
    6.3 Asia-Pacific Antibodies Sales, Revenue and Market Share by Type (2018-2021)
        6.3.1 Asia-Pacific Antibodies Sales Market Share by Type (2018-2021)
        6.3.2 Asia-Pacific Antibodies Revenue and Revenue Share by Type (2018-2021)
    6.4 Asia-Pacific Antibodies Sales and Market Share by Application (2018-2021)

7 North America Antibodies Market Size Categorized by Countries
    7.1 North America Antibodies Sales, Revenue and Market Share by Countries
        7.1.1 North America Antibodies Sales by Countries (2018-2021)
        7.1.2 North America Antibodies Revenue by Countries (2018-2021)
        7.1.3 United States Antibodies Sales and Growth Rate (2018-2021)
        7.1.4 Canada Antibodies Sales and Growth Rate (2018-2021)
        7.1.5 Mexico Antibodies Sales and Growth Rate (2018-2021)
    7.2 North America Antibodies Revenue (Value) by Manufacturers (2018-2021)
    7.3 North America Antibodies Sales, Revenue and Market Share by Type (2018-2021)
        7.3.1 North America Antibodies Sales Market Share by Type (2018-2021)
        7.3.2 North America Antibodies Revenue and Revenue Share by Type (2018-2021)
    7.4 North America Antibodies Sales Market Share by Application (2018-2021)

8 South America Antibodies Market Size Categorized by Countries
    8.1 South America Antibodies Sales, Revenue and Market Share by Countries
        8.1.1 South America Antibodies Sales by Countries (2018-2021)
        8.1.2 South America Antibodies Revenue by Countries (2018-2021)
        8.1.3 Brazil Antibodies Sales and Growth Rate (2018-2021)
    8.2 South America Antibodies Revenue (Value) by Manufacturers (2018-2021)
    8.3 South America Antibodies Sales, Revenue and Market Share by Type (2018-2021)
        8.3.1 South America Antibodies Sales Market Share by Type (2018-2021)
        8.3.2 South America Antibodies Revenue and Revenue Share by Type (2018-2021)
    8.4 South America Antibodies Sales Market Share by Application (2018-2021)

9 Middle East and Africa Antibodies Market Size Categorized by Countries
    9.1 Middle East and Africa Antibodies Sales, Revenue and Market Share by Countries
        9.1.1 Middle East and Africa Antibodies Sales by Countries (2018-2021)
        9.1.2 Middle East and Africa Antibodies Revenue by Countries (2018-2021)
        9.1.3 GCC Countries Antibodies Sales and Growth Rate (2018-2021)
        9.1.4 Turkey Antibodies Sales and Growth Rate (2018-2021)
        9.1.5 Egypt Antibodies Sales and Growth Rate (2018-2021)
        9.1.6 South Africa Antibodies Sales and Growth Rate (2018-2021)
    9.2 Middle East and Africa Antibodies Revenue (Value) by Manufacturers (2018-2021)
    9.3 Middle East and Africa Antibodies Sales, Revenue and Market Share by Type
        9.3.1 Middle East and Africa Antibodies Sales Market Share by Type (2018-2021)
        9.3.2 Middle East and Africa Antibodies Revenue and Revenue Share by Type (2018-2021)
    9.4 Middle East and Africa Antibodies Sales Market Share by Application (2018-2021)

10 Global Antibodies Market Segment by Type
    10.1 Global Antibodies Revenue, Sales and Market Share by Type (2018-2021)
        10.1.1 Global Antibodies Sales and Market Share by Type (2018-2021)
        10.1.2 Global Antibodies Revenue and Market Share by Type (2018-2021)
    10.2 Infliximab Sales Growth Rate and Price
        10.2.1 Global Infliximab Sales Growth Rate (2018-2021)
        10.2.2 Global Infliximab Price (2018-2021)
    10.3 Rituximab Sales Growth Rate and Price
        10.3.1 Global Rituximab Sales Growth Rate (2018-2021)
        10.3.2 Global Rituximab Price (2018-2021)
    10.4 Trastuzumab Sales Growth Rate and Price
        10.4.1 Global Trastuzumab Sales Growth Rate (2018-2021)
        10.4.2 Global Trastuzumab Price (2018-2021)
    10.5 Adalimumab Sales Growth Rate and Price
        10.5.1 Global Adalimumab Sales Growth Rate (2018-2021)
        10.5.2 Global Adalimumab Price (2018-2021)
    10.6 Other Sales Growth Rate and Price
        10.6.1 Global Other Sales Growth Rate (2018-2021)
        10.6.2 Global Other Price (2018-2021)

11 Global Antibodies Market Segment by Application
    11.1 Global AntibodiesSales Market Share by Application (2018-2021)
    11.2 Oncology Sales Growth Rate (2018-2021)
    11.3 Autoimmune Disease Sales Growth Rate (2018-2021)
    11.4 Other Sales Growth Rate (2018-2021)

12 Market Forecast for Antibodies
    12.1 Global Antibodies Revenue, Sales and Growth Rate (2022-2030)
    12.2 Antibodies Market Forecast by Regions (2022-2030)
        12.2.1 Europe Antibodies Market Forecast (2022-2030)
        12.2.2 APAC Antibodies Market Forecast (2022-2030)
        12.2.3 North America Antibodies Market Forecast (2022-2030)
        12.2.4 South America Antibodies Market Forecast (2022-2030)
        12.2.5 Middle East & Africa Antibodies Market Forecast (2022-2030)
    12.3 Antibodies Market Forecast by Type (2022-2030)
        12.3.1 Global Antibodies Sales Forecast by Type (2022-2030)
        12.3.2 Global Antibodies Market Share Forecast by Type (2022-2030)
    12.4 Antibodies Market Forecast by Application (2022-2030)
        12.4.1 Global Antibodies Sales Forecast by Application (2022-2030)
        12.4.2 Global Antibodies Market Share Forecast by Application (2022-2030)

13 Analysis of Antibodies Industry Key Manufacturers
    13.1 Celltrion
        13.1.1 Company Details
        13.1.2 Product Information
        13.1.3 Celltrion Antibodies Production, Price, Cost, Gross Margin, and Revenue (2018-2021)
        13.1.4 Main Business Overview
        13.1.5 Celltrion News
    13.2 Pfizer (Hospira)
        13.2.1 Company Details
        13.2.2 Product Information
        13.2.3 Pfizer (Hospira) Antibodies Production, Price, Cost, Gross Margin, and Revenue (2018-2021)
        13.2.4 Main Business Overview
        13.2.5 Pfizer (Hospira) News
    13.3 3SBIO
        13.3.1 Company Details
        13.3.2 Product Information
        13.3.3 3SBIO Antibodies Production, Price, Cost, Gross Margin, and Revenue (2018-2021)
        13.3.4 Main Business Overview
        13.3.5 3SBIO News
    13.4 Novartis (Sandoz)
        13.4.1 Company Details
        13.4.2 Product Information
        13.4.3 Novartis (Sandoz) Antibodies Production, Price, Cost, Gross Margin, and Revenue (2018-2021)
        13.4.4 Main Business Overview
        13.4.5 Novartis (Sandoz) News
    13.5 Dr ReddyÕs
        13.5.1 Company Details
        13.5.2 Product Information
        13.5.3 Dr ReddyÕs Antibodies Production, Price, Cost, Gross Margin, and Revenue (2018-2021)
        13.5.4 Main Business Overview
        13.5.5 Dr ReddyÕs News
    13.6 Celgen Biopharma
        13.6.1 Company Details
        13.6.2 Product Information
        13.6.3 Celgen Biopharma Antibodies Production, Price, Cost, Gross Margin, and Revenue (2018-2021)
        13.6.4 Main Business Overview
        13.6.5 Celgen Biopharma News
    13.7 Cadila Healthcare
        13.7.1 Company Details
        13.7.2 Product Information
        13.7.3 Cadila Healthcare Antibodies Production, Price, Cost, Gross Margin, and Revenue (2018-2021)
        13.7.4 Main Business Overview
        13.7.5 Cadila Healthcare News
    13.8 Hisun Pharma
        13.8.1 Company Details
        13.8.2 Product Information
        13.8.3 Hisun Pharma Antibodies Production, Price, Cost, Gross Margin, and Revenue (2018-2021)
        13.8.4 Main Business Overview
        13.8.5 Hisun Pharma News
    13.9 Torrent Pharmaceuticals
        13.9.1 Company Details
        13.9.2 Product Information
        13.9.3 Torrent Pharmaceuticals Antibodies Production, Price, Cost, Gross Margin, and Revenue (2018-2021)
        13.9.4 Main Business Overview
        13.9.5 Torrent Pharmaceuticals News

14 Research Findings and Conclusion

15 Appendix

Search results for Pharmaceutical Industry

Select License Type

get a sample
Ask For Customization
Get a quote
Speak to Analyst
Buy Now

Chemical & Materials

Top Rated Products